The seven-building North San Jose office park, acquired by PCCP and Blue Rise Ventures for $144.5 million in 2018 and repositioned as a...
ByThe RegistryMarch 26, 2026The biomedical research nonprofit plans to hire 300 scientists and build 30 new labs as it expands its AI-driven drug discovery programs despite...
ByThe RegistryMarch 25, 2026The developer’s rezoning proposal, paired with a $6.3 million community benefit package, clears its final public hearing hurdles as the Peninsula office market...
ByThe RegistryMarch 23, 2026The region posted its first year of net occupancy gains after 2 consecutive years of losses, driven by large-block leasing and user purchases...
ByThe RegistryMarch 19, 2026At the ACREM “State of the Peninsula” breakfast, commercial real estate leaders described surging tenant demand, rising return-to-office momentum, and the first signs...
ByThe RegistryMarch 3, 2026King Street Properties, specializing in purpose-built life science space, welcomes anti-aging innovator to The Landing at 1699-1701 Bayshore Hwy, Burlingame CA Burlingame, CA...
ByThe RegistryFebruary 18, 2026UCSF’s 280,000-square-foot anchor lease, AI-driven SoMa activity, and a 65 percent surge in the forward pipeline underscore accelerating fundamentals across the REIT’s largest...
ByThe RegistryFebruary 11, 2026Balloon-based weather startup expands footprint as production plans accelerate As climate data, artificial intelligence and hardware manufacturing converge, technology companies with physical production...
ByThe RegistryFebruary 10, 2026The biotech pioneer will raze 18 buildings and nearly double its footprint to 9 million square feet as it marks its 50th anniversary...
ByThe RegistryFebruary 9, 2026Six-story property 100 percent leased to tech giant through 2030 returns to market three years after $17.6 million acquisition Long Market Property Partners...
ByThe RegistryFebruary 5, 2026Life sciences leasing activity surged on the San Francisco Peninsula in Q4 2025 Burlingame – February 4, 2026 – Premia Capital, Prince Street Partners and CBRE...
ByThe RegistryFebruary 5, 2026Glioblastoma Treatment Developer Establishes Custom Laboratory Infrastructure for CNS Drug Delivery Platform Precision NeuroMed, a clinical-stage neuroscience company developing treatments for glioblastoma and...
ByThe RegistryFebruary 4, 2026